Viagra’s brand owner has suspended deliveries of the erectile dysfunction pill to Russia, the country’s Industry and Trade Ministry said Wednesday.
The U.S. pharmaceutical corporation Viatris had notified Russia of the suspension as far back as early 2022 following Moscow’s initial invasion of Ukraine, the ministry told Interfax.
Russia’s Industry and Trade Ministry said domestic manufacturers have the capacity to produce their own versions of Viagra based on past clinical trials organized in the country.
Russia’s Health Ministry said pharmacies are not experiencing shortages of generic medication that contains the substance called Sildenafil, which is sold under the brand name Viagra.
Russian pharmaceuticals increased production of drugs containing Sildenafil by 11% in January-September 2022, according to Interfax.
Sales of the medication that treats sexual dysfunction went up by 15% over the same period, the news agency added.
Other studies cited by the Kommersant business daily say Russians bought 2.7 million erectile dysfunction pills in mid-2022, an 88% jump from the same time in 2021.
A Message from The Moscow Times:
Dear readers,
We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."
These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.
We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.
Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.
By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.
Remind me later.
